The normal placenta is composed of fetal and maternal components. Which is the MOST inner component of the placenta?
Which of the following conditions is not transmitted from the female parent?
Oogonia are derived from which embryonic structure?
A neonate is born with a gross deformity of her lower back. Examination of the subcutaneous lesion reveals disorganized neural tissue with entrapment of nerve roots. The parents are concerned about the risks for similar birth defects in their future offspring. You explain that supplementation of the maternal diet can reduce the incidence of neural tube defects. What is this important dietary supplement?
Homeobox genes are primarily responsible for which of the following aspects of embryonic development?
What is the approximate size of a human ovum?
All of the following are neural tube defects except?
At which stage of gestation do septal defects in the fetal heart develop?
Which of the following features is NOT present in a fetus of four months intrauterine life?
What is the typical number of cells in a morula?
Explanation: ### Explanation The placenta is a complex organ formed by both maternal and fetal tissues [1]. To identify the "inner" component, one must look at the **placental membrane (barrier)** from the perspective of the fetal blood. **1. Why Syncytiotrophoblast is Correct:** The placental barrier separates fetal blood from maternal blood. Moving from the fetal side toward the maternal side (the intervillous space), the layers are: 1. Fetal capillary endothelium 2. Connective tissue (mesoderm) of the villus [2] 3. Cytotrophoblast 4. **Syncytiotrophoblast** (The outermost fetal layer) [1] In the context of the **placenta as a whole unit**, the syncytiotrophoblast is the layer in direct contact with the maternal blood in the intervillous space [1]. It is considered the "most inner" functional component of the maternal-fetal interface because it lines the lacunae where gas and nutrient exchange occurs. **2. Analysis of Incorrect Options:** * **Decidua basalis (A):** This is the **maternal component** of the placenta [1]. It forms the floor of the placental bed and is the outermost layer relative to the fetus. * **Nitabuch layer (B):** This is a zone of fibrinoid degeneration where the trophoblast meets the decidua. It is a boundary layer, not the innermost functional layer. * **Cytotrophoblast (C):** This is the inner layer of the trophoblast (Langhans layer). While it is "inner" to the syncytiotrophoblast, it disappears in many areas during late pregnancy, leaving the syncytiotrophoblast as the primary barrier [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Placental Barrier:** In early pregnancy, it has 4 layers. In late pregnancy, it thins to 2 layers (Syncytiotrophoblast and Fetal Endothelium) to facilitate faster diffusion [2]. * **hCG Production:** The **Syncytiotrophoblast** is responsible for secreting Human Chorionic Gonadotropin (hCG). * **Rohr’s Stria:** Another fibrinoid deposit found at the bottom of the intervillous space and surrounding the attachment of the villi. * **Placenta Accreta:** Occurs when the placenta adheres directly to the myometrium due to the absence of the **Decidua basalis** (specifically the Nitabuch layer).
Explanation: ### Explanation The core concept tested here is the **mode of inheritance**, specifically distinguishing between Mitochondrial, X-linked, and Autosomal patterns. **1. Why Limb-girdle muscular Dystrophy (LGMD) is the correct answer:** LGMD is primarily inherited as an **Autosomal Recessive** (LGMD R) or **Autosomal Dominant** (LGMD D) condition [1]. Because it is autosomal, the defective gene can be transmitted by **either** the male or female parent. The question asks which condition is *not* exclusively or characteristically transmitted from the female parent; since LGMD can come from the father, it fits the criteria. **2. Analysis of Incorrect Options:** * **Kearns-Sayre Syndrome & MERRF (Options B & C):** These are classic **Mitochondrial Myopathies**. Mitochondrial DNA is inherited exclusively via the **matrilineal line** (from the mother) because the sperm contributes negligible cytoplasm/mitochondria to the zygote [2]. Therefore, these are always transmitted from the female parent. * **Duchenne Muscular Dystrophy (Option A):** This is an **X-linked Recessive** disorder. While spontaneous mutations occur, when it is inherited, it is transmitted from a carrier **female parent** to her affected son. **3. NEET-PG High-Yield Pearls:** * **Mitochondrial Inheritance:** Look for "Ragged Red Fibers" on Gomori trichrome stain. All children of an affected mother are at risk, but children of an affected father are never affected. * **Mnemonic for Mitochondrial Diseases:** **MELAS** (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes), **MERRF**, and **Leber’s** Hereditary Optic Neuropathy. * **LGMD:** Characterized by progressive weakness of the proximal pelvic and shoulder girdle muscles; unlike DMD, it affects both males and females equally due to its autosomal nature [1].
Explanation: The correct answer is **B. Yolk sac**. **Underlying Medical Concept:** Primordial Germ Cells (PGCs), which are the precursors to both oogonia (in females) and spermatogonia (in males), do not originate within the developing gonads. Instead, they first appear during the **3rd week** of development in the **epiblast**. During the **4th week**, they migrate via ameboid movement to the **endodermal lining of the yolk sac** (specifically near the allantois) [1]. Between the 4th and 6th weeks, they migrate along the dorsal mesentery of the hindgut [1] to reach the **genital ridges** (primitive gonads). If PGCs fail to reach the ridges, the gonads will not develop. **Why the other options are incorrect:** * **Amnion:** The amnion forms the fluid-filled sac surrounding the embryo; it does not contribute to the germ cell line. * **Stroma of ovary:** The ovarian stroma is derived from the **mesenchyme** of the genital ridge, providing the structural framework, not the germ cells themselves. * **Germinal epithelium:** Despite its misleading name, this is the simple cuboidal epithelium (modified peritoneum) covering the ovary. Historically, it was thought to give rise to germ cells, but we now know it only gives rise to **follicular (granulosa) cells**. **High-Yield Facts for NEET-PG:** * **Migration Path:** Epiblast → Yolk sac wall → Hindgut mesentery → Genital ridge [1]. * **Clinical Correlation:** If PGCs stray from their migratory path and lodge in extragonadal sites, they can give rise to **Sacrococcygeal Teratomas** (the most common tumor in newborns). * **Timeline:** Oogonia reach their peak population (approx. 7 million) by the **5th month** of intrauterine life.
Explanation: **Explanation:** The clinical presentation describes a **Neural Tube Defect (NTD)**, specifically **Myelomeningocele**, characterized by the protrusion of the spinal cord and meninges through a vertebral defect [1]. **1. Why Folic Acid is Correct:** Neural tube closure occurs between **days 21 and 28** of gestation (often before a woman knows she is pregnant). **Folic acid (Vitamin B9)** is a crucial co-enzyme for DNA synthesis and methylation [2]. Deficiency leads to impaired cell proliferation during the fusion of the neural folds. Supplementation significantly reduces the incidence of NTDs (like spina bifida and anencephaly) by up to 70%. **2. Why Other Options are Incorrect:** * **Niacin (B3):** Deficiency causes Pellagra (Dermatitis, Diarrhea, Dementia, Death). While it is vital for metabolic redox reactions, it is not specifically linked to neural tube closure. * **Thiamine (B1):** Deficiency leads to Beriberi or Wernicke-Korsakoff syndrome. It is essential for glucose metabolism but not primary neurulation. * **Vitamin B6 (Pyridoxine):** Used to treat pregnancy-induced nausea and as an adjunct in tuberculosis treatment (with Isoniazid), but it does not prevent NTDs. **3. High-Yield Clinical Pearls for NEET-PG:** * **Dosage:** The standard dose for low-risk pregnancies is **400 mcg (0.4 mg)** daily [2]. For high-risk cases (previous child with NTD or mother on anticonvulsants like Valproate), the dose is **4 mg** daily. * **Timing:** Supplementation must begin **at least 1 month preconception** and continue through the first trimester. * **Screening:** Elevated **Alpha-fetoprotein (AFP)** in maternal serum and amniotic fluid is a marker for open NTDs [3]. Acetylcholinesterase levels in amniotic fluid are also increased. * **Mechanism:** Anticonvulsants (Valproate, Carbamazepine) and Methotrexate act as folic acid antagonists, increasing the risk of NTDs.
Explanation: **Explanation:** **1. Why Option A is Correct:** Homeobox (HOX) genes are a highly conserved group of regulatory genes that contain a specific 180-nucleotide sequence called the **homeobox**. They encode transcription factors that determine the **positional identity** of cells along the **craniocaudal (anteroposterior) axis**. In humans, 39 HOX genes are organized into four clusters (HOXA, B, C, and D) on different chromosomes. They exhibit "temporal and spatial colinearity," meaning the order of genes on the chromosome corresponds to the order and timing of their expression along the body axis, ensuring that organs and segments develop in the correct anatomical location. **2. Why Other Options are Incorrect:** * **Option B:** Dorsal-ventral axis patterning is primarily regulated by other signaling molecules, most notably **BMP-4** (ventralizing) and **Sonic Hedgehog (Shh)** or proteins like **Noggin/Chordin** (dorsalizing). * **Option C:** The lengthening of limbs is primarily driven by the **Apical Ectodermal Ridge (AER)** through the secretion of **Fibroblast Growth Factors (FGFs)**. While HOX genes do influence the *patterning* of limb segments (e.g., stylopod, zeugopod), they are not the primary stimulators for longitudinal growth. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Synpolydactyly:** Mutations in the **HOXD13** gene lead to this condition (fusion and extra digits). * **Hand-Foot-Genital Syndrome:** Associated with mutations in the **HOXA13** gene. * **Retinoic Acid (Vitamin A):** It is a potent teratogen because it alters the expression of HOX genes, leading to severe craniofacial and axial skeletal defects. * **Sonic Hedgehog (Shh):** Key for the **Left-Right axis** and the **Zone of Polarizing Activity (ZPA)** in limb development.
Explanation: ### Explanation **1. Why Option A is Correct:** The human ovum (secondary oocyte) is the largest cell in the human body. Its diameter is approximately **0.133 mm (or 133 micrometers)**. This size is significant because, unlike most human cells, the ovum is just barely visible to the naked eye. The large volume is primarily due to the accumulation of cytoplasm (ooplasm), which contains the nutrients and organelles necessary to support the initial stages of cleavage after fertilization before the embryo implants in the uterus [1]. **2. Why the Other Options are Incorrect:** * **Option B (0.144 mm):** While some older texts or specific measurements might show slight variations, 0.133 mm is the standard value cited in core embryology textbooks (like Langman’s or Inderbir Singh) used for medical examinations. * **Option C (0.2 mm):** This is an overestimation. While the ovum plus the surrounding **zona pellucida and corona radiata** might approach this size, the ovum itself does not reach 200 micrometers [3]. * **Option D:** Incorrect, as 0.133 mm is the established anatomical standard. **3. NEET-PG High-Yield Facts & Clinical Pearls:** * **Largest vs. Smallest:** The **ovum** is the largest cell in the human body (0.133 mm), while the **spermatozoon** is one of the smallest (head size ~5 µm), though it is the longest cell if the tail is included in some contexts. However, the **Cerebellar Granule Cell** is often cited as the smallest cell by volume. * **State of Arrest:** At ovulation, the ovum is arrested in **Metaphase of Meiosis II** [2]. It only completes meiosis if fertilization occurs [4]. * **Visibility:** The ovum is the only human cell that can be seen without the aid of a microscope (appearing as a tiny speck). * **Zona Pellucida:** This is a glycoprotein coat surrounding the ovum that prevents **polyspermy** via the cortical reaction [3].
Explanation: **Explanation:** **Neural Tube Defects (NTDs)** result from the failure of the neural tube to close during the 3rd and 4th weeks of development (primary neurulation). [1] Closure occurs bidirectionally, starting from the cervical region toward the cranial and caudal neuropores. **Why Holoprosencephaly is the Correct Answer:** Holoprosencephaly is **not** a defect of neural tube closure. Instead, it is a **prosencephalic cleavage defect**. It occurs when the embryonic forebrain (prosencephalon) fails to sufficiently divide into two distinct cerebral hemispheres. It is frequently associated with sonic hedgehog (SHH) signaling pathway mutations and trisomy 13 (Patau syndrome). **Analysis of Incorrect Options (NTDs):** * **Anencephaly:** Results from the failure of the **cranial (anterior) neuropore** to close. [3] This leads to the absence of a major portion of the brain and skull. * **Encephalocele:** A defect in the cranium (usually occipital) resulting in the herniation of brain tissue and meninges. [1] * **Myelomeningocele:** A severe form of **Spina Bifida** resulting from the failure of the **caudal (posterior) neuropore** to close. [2] It involves the herniation of both the spinal cord and meninges through a vertebral defect. **High-Yield Clinical Pearls for NEET-PG:** * **Biomarkers:** NTDs are associated with **elevated Alpha-fetoprotein (AFP)** in maternal serum and amniotic fluid, and increased **Acetylcholinesterase (AChE)** in amniotic fluid. [1], [3] * **Prevention:** Periconceptional supplementation of **Folic acid (0.4 mg/day)** significantly reduces the risk of NTDs. * **Holoprosencephaly Clue:** Look for midline facial defects, such as **cyclopia** or a cleft lip/palate, in the clinical vignette.
Explanation: The development of the heart is a complex process occurring primarily during the embryonic period. The correct answer is **6-8 weeks** because this is the critical window when **septation** of the heart chambers and the outflow tract is finalized. 1. **Why 6-8 weeks is correct:** While heart development begins earlier, the formation of the **interventricular septum** and the completion of the **atrial septum** (specifically the closure of the ostium secundum and formation of the septum secundum) occur between the 6th and 8th weeks. Most clinically significant septal defects, including Ventricular Septal Defects (VSD) and Atrial Septal Defects (ASD), result from errors during this specific window of morphogenesis. 2. **Why other options are incorrect:** * **3-5 weeks:** This is the period of **gastrualtion and heart tube formation**. While the heart starts beating around day 22 [1], the internal septa have not yet fully formed to create distinct chambers. * **9-12 weeks:** By this stage, the heart is structurally complete. This period is characterized by functional maturation and growth rather than primary organogenesis. * **13-15 weeks:** This is well into the second trimester; the organogenetic period is over, and the risk of structural congenital malformations is minimal. **High-Yield NEET-PG Pearls:** * **Most common congenital heart disease (CHD):** VSD (specifically the membranous type). * **Neural Crest Cells:** Essential for the development of the **conotruncal septum**; defects here lead to Tetralogy of Fallot or Transposition of Great Arteries. * **Endocardial Cushions:** Give rise to the lower part of the atrial septum and the upper part of the ventricular septum [2]. Defects here are common in **Down Syndrome**.
Explanation: The development of a fetus follows a predictable chronological sequence. At **four months (16 weeks)** of intrauterine life, the fetus undergoes significant growth and differentiation, but certain features are characteristic of later stages. **Why Option C is the Correct Answer:** Nails begin to develop as early as the 10th week, but they are still very short at four months. **Nails only reach the tips of the fingers by the end of the 8th month (32 weeks)** and the tips of the toes by the 9th month (36 weeks). Therefore, nails extending to the fingertips is a feature of a late-third-trimester fetus, not a four-month-old fetus. **Analysis of Incorrect Options:** * **A. Length of 16 cm:** According to **Haase’s Rule** for fetal length, for the first five months, the length (in cm) is the square of the month in months ($4^2 = 16$ cm). Thus, 16 cm is the standard Crown-Heel length at 4 months. * **B. Sex can be recognized:** External genitalia begin to differentiate by the 9th week and are clearly distinguishable by the **12th to 14th week**. By the 4th month (16 weeks), the sex is easily recognizable via ultrasound [1]. * **D. Presence of meconium:** The fetus begins swallowing amniotic fluid around the 10th–12th week. Meconium (composed of intestinal epithelial cells, mucus, and bile) begins to accumulate in the gastrointestinal tract (duodenum and ileum) by the **16th week**. **High-Yield Clinical Pearls for NEET-PG:** * **Haase’s Rule:** 1-5 months = $Month^2$; 6-10 months = $Month \times 5$ [1]. * **Quickening:** Maternal perception of fetal movements occurs at 18–20 weeks in primigravida and 16–18 weeks in multigravida. * **Vernix Caseosa & Lanugo:** Appear prominently during the 5th month (20 weeks). * **Viability:** Traditionally considered 24 weeks (weight approx. 500g).
Explanation: **Explanation:** The development of a human embryo begins with fertilization, followed by a series of rapid mitotic divisions known as **cleavage**. 1. **Why 16 is the correct answer:** The term **Morula** (Latin for "mulberry") refers to the solid ball of cells formed after several rounds of cleavage [1]. While some texts describe the morula stage starting at 12 cells, the standard medical definition for the **mature morula**—the stage just before it enters the uterine cavity and begins fluid absorption—is **16 cells** [1]. This occurs approximately 3 to 4 days after fertilization [1]. At this stage, the cells undergo **compaction**, where they maximize contact with each other, forming an inner cell mass (embryoblast) and an outer cell mass (trophoblast) [1]. 2. **Analysis of incorrect options:** * **Option A (8 cells):** This is the stage immediately preceding the morula. At the 8-cell stage, the blastomeres are loosely arranged; compaction begins *after* this stage to form the morula. * **Option C (32 cells):** By the time the embryo reaches the 32-cell stage, fluid begins to collect inside, forming a cavity (blastocele). At this point, it is no longer a solid morula but is termed a **Blastocyst**. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** The morula typically enters the uterine cavity on **Day 4** post-fertilization [1]. * **Zona Pellucida:** The morula is still enclosed within the *zona pellucida*, which prevents premature implantation in the fallopian tube (ectopic pregnancy) [1]. * **Potency:** Blastomeres up to the 8-cell stage are **totipotent** (can form an entire organism), whereas cells in the blastocyst become pluripotent.
Gametogenesis and Fertilization
Practice Questions
Early Embryonic Development
Practice Questions
Placentation
Practice Questions
Development of Nervous System
Practice Questions
Development of Cardiovascular System
Practice Questions
Development of Gastrointestinal System
Practice Questions
Development of Urogenital System
Practice Questions
Development of Musculoskeletal System
Practice Questions
Development of Head and Neck
Practice Questions
Congenital Anomalies
Practice Questions
Teratology
Practice Questions
Molecular Mechanisms in Development
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free